NOVOZYMES A/S: Financial statements 2014
CVR: 10007127
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
NOVOZYMES A/S (CVR 10007127) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 12,459,000,000 and a net result of DKK 2,525,000,000. The profit margin was 20.3%. Equity in the 2014 report amounted to DKK 11,280,000,000. The solvency ratio was 61.2%.
- Revenue
- DKK 12,459,000,000
- Gross Profit
- DKK 7,149,000,000
- Profit/Loss
- DKK 2,525,000,000
- Equity
- DKK 11,280,000,000
- Total Assets
- DKK 18,426,000,000
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
NOVOZYMES A/S has published its interim report for the period July 1, 2014 to September 30, 2014.
NOVOZYMES A/S has published its interim report for the period January 1, 2014 to June 30, 2014.
NOVOZYMES A/S has published its interim report for the period January 1, 2014 to March 31, 2014.
NOVOZYMES A/S has published its annual report for 2013.
As of February 26, 2014, Agnete Raaschou-Nielsen has joined the board of directors of NOVOZYMES A/S.
As of February 26, 2014, Lars Green has joined the board of directors of NOVOZYMES A/S.
As of February 26, 2014, Kurt Anker Nielsen has left the board of directors of NOVOZYMES A/S.
About NOVOZYMES A/S
NOVOZYMES A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2000. The company is registered under the industry Fremstilling af andre organiske basiskemikalier. The management consists of Ester Baiget Arnau and Rainer Chapour Lehmann. The board consists of Cornelis de Jong (chair), Heine Dalsgaard, Frederikke Rose Spenner and Kasim Kutay. The company is owned by Novo Holdings A/S and BlackRock, Inc.. The company has 3,508 employees (2026). In 2025, the company reported revenue of EUR 4,157,600,000 and a net result of EUR 583,600,000 compared with EUR 305,800,000 the year before. Equity in the 2025 report amounted to EUR 10,855,200,000.